Targeted Oncology™ brings you Targeted Talks, a monthly podcast featuring discussions with academic and community oncologists surrounding advancements in cancer research and best practices for patient management.
Modern Strategies Improving Immunotherapy in Cancer
Jason Luke, MD, leads a discussion with Sandip Patel, MD, about the present and future of immunotherapy in cancer.
The Impact of the Gut Microbiome in Young Patients With Colorectal Cancer
In season 2, episode 2 of Targeted Talks, Cathy Eng, MD, speaks with Benjamin Weinberg, MD, about the gut microbiome, and how the presence of certain microbiota impact the onset and intensity of disease as well as the potential response to certain treatments.
Therapies on the Horizon in EGFR Exon 20–Positive Lung Cancer
In season 2, episode 1 of Targeted Talks, Nagashree Seetharamu, MD, led a conversation with Luis E. Raez, MD, about the evolving treatment landscape for EGFR exon 20–mutated lung cancer.
COVID-19 Leaves Its Mark on Oncology Care
In season 1, episode 5 of Targeted Talks, Debra Patt, MD, PhD, MBA, speaks with Alex Spira, MD, PhD, FACP, about the impact of the COVID-19 pandemic on community cancer centers and hospitals in the United States.
Prostate Cancer Sees Surge of PARP Inhibition Strategies
In season 1, episode 4 of Targeted Talks, Michael Schweizer, MD, spoke with fellow oncologist, Winston Tan, MD, about the ever-changing treatment landscape for prostate cancer.
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Precision Medicine Guiding Ovarian Cancer Treatment
Sarah M. Temkin, MD leads discussion with Daphne B. Stewart, MD, around targeted therapies in ovarian cancer, whether offered in the academic or community setting.
2 Clarke Drive Cranbury, NJ 08512